{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:25:45Z","timestamp":1790825145208,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The literature describes a case of systemic lupus erythematosus (SLE) complicated with Castleman\u2019s disease (CD) and secondary paraneoplastic pemphigus (PNP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 12-year-old female presented with a neck mass, rash, arthralgia, and skin and mouth ulceration for 5 years were admitted. All blood cells were low. Multiple autoantibodies associated with SLE were positive. The pathology of the neck mass revealed the classical manifestations of CD. She was treated with prednisone, hydroxychloroquine, leflunomide, thalidomide, and dressings. Pathological examination of the skin revealed PNP. The neck mass was removed and continued to take antirheumatic drugs. At subsequent follow-up, the patient\u2019s disease status was stable and the skin mucosal lesion did not recur.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The case of simultaneous SLE, CD, and PNP in children was rarely reported, and the correct diagnosis of the disease will help to take timely treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-023-00871-2","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T08:01:49Z","timestamp":1697702509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Systemic lupus erythematosus combined with Castleman disease and secondary paraneoplastic pemphigus: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0980-8750","authenticated-orcid":false,"given":"Xin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaishao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"6","key":"871_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"871_CR2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/ard.2009.117200","volume":"69","author":"M Mosca","year":"2010","unstructured":"Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, et al. European League against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010;69(7):1269\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"871_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1080\/14397595.2018.1494239","volume":"28","author":"K Oku","year":"2018","unstructured":"Oku K, Atsumi T. Systemic lupus erythematosus: nothing stale her infinite variety. Mod Rheumatol. 2018;28(5):758\u201365.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"871_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.berh.2018.09.004","volume":"32","author":"I Gergianaki","year":"2018","unstructured":"Gergianaki I, Bortoluzzi A, Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2018;32(2):188\u2013205.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313.","journal-title":"J Autoimmun"},{"issue":"3","key":"871_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.blre.2017.11.005","volume":"32","author":"M Haap","year":"2018","unstructured":"Haap M, Wiefels J, Horger M, Hoyer A, Mussig K. Clinical, laboratory and imaging findings in Castleman\u2019s disease - the subtype decides. Blood Rev. 2018;32(3):225\u201334.","journal-title":"Blood Rev"},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/JBM.S60514","volume":"7","author":"KL Chan","year":"2016","unstructured":"Chan KL, Lade S, Prince HM, Harrison SJ. Update and new approaches in the treatment of Castleman disease. J Blood Med. 2016;7:145\u201358.","journal-title":"J Blood Med"},{"issue":"1","key":"871_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hoc.2017.09.008","volume":"32","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, Greenway A, Stone K. Treatment of Idiopathic Castleman Disease. Hematol Oncol Clin North Am. 2018;32(1):89\u2013106.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"20","key":"871_CR9","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","volume":"132","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A, Fossa A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115\u201324.","journal-title":"Blood"},{"issue":"10201","key":"871_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","volume":"394","author":"E Schmidt","year":"2019","unstructured":"Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019;394(10201):882\u201394.","journal-title":"Lancet"},{"issue":"2","key":"871_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.iac.2012.04.003","volume":"32","author":"SS Venugopal","year":"2012","unstructured":"Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Immunol Allergy Clin North Am. 2012;32(2):233\u201343. v-vi.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"871_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clindermatol.2013.01.005","volume":"31","author":"E Ruocco","year":"2013","unstructured":"Ruocco E, Wolf R, Ruocco V, Brunetti G, Romano F, Lo Schiavo A. Pemphigus: associations and management guidelines: facts and controversies. Clin Dermatol. 2013;31(4):382\u201390.","journal-title":"Clin Dermatol"},{"issue":"1","key":"871_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","volume":"30","author":"M Meurer","year":"2012","unstructured":"Meurer M. Immunosuppressive therapy for autoimmune bullous diseases. Clin Dermatol. 2012;30(1):78\u201383.","journal-title":"Clin Dermatol"},{"issue":"8","key":"871_CR14","doi-asserted-by":"publisher","first-page":"e6184","DOI":"10.1097\/MD.0000000000006184","volume":"96","author":"Q Jiang","year":"2017","unstructured":"Jiang Q, Zhang BH. Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: a case report. Med (Baltim). 2017;96(8):e6184.","journal-title":"Med (Baltim)"},{"issue":"3","key":"871_CR15","first-page":"265","volume":"11","author":"S Shariatpanahi","year":"2016","unstructured":"Shariatpanahi S, Pourfarzam S, Gheini M. Association of Macrophage activating syndrome with Castleman\u2019s syndrome in systemic Lupus Erythematosus. Iran J Pathol. 2016;11(3):265\u201371.","journal-title":"Iran J Pathol"},{"issue":"7","key":"871_CR16","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00296-010-1451-0","volume":"32","author":"JY Xia","year":"2012","unstructured":"Xia JY, Chen XY, Xu F, Yang Y, Wang HY, Xue J. A case report of systemic lupus erythematosus combined with Castleman\u2019s disease and literature review. Rheumatol Int. 2012;32(7):2189\u201393.","journal-title":"Rheumatol Int"},{"issue":"1","key":"871_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02238769","volume":"16","author":"F Gohlke","year":"1997","unstructured":"Gohlke F, Marker-Hermann E, Kanzler S, Mitze M, Meyer zum Buschenfelde KH. Autoimmune findings resembling connective tissue disease in a patient with Castleman\u2019s disease. Clin Rheumatol. 1997;16(1):87\u201392.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"871_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00043426-200003000-00021","volume":"22","author":"R Simko","year":"2000","unstructured":"Simko R, Nagy K, Lombay B, Kiss A, Minik K, Lukacs VH, Vamosi I. Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol. 2000;22(2):180\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"871_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00296-020-04684-4","volume":"41","author":"FG Demirkan","year":"2021","unstructured":"Demirkan FG, Dogan S, Kalyoncu Ucar A, Sonmez HE, Aktay Ayaz N. Systemic lupus erythematosus complicated with Castleman disease: a case-based review. Rheumatol Int. 2021;41(2):475\u20139.","journal-title":"Rheumatol Int"},{"issue":"38","key":"871_CR20","doi-asserted-by":"publisher","first-page":"e12291","DOI":"10.1097\/MD.0000000000012291","volume":"97","author":"L Wang","year":"2018","unstructured":"Wang L, Chen H, Shi J, Tang H, Li H, Zheng W, Zhang F. Castleman disease mimicking systemic lupus erythematosus: a case report. Med (Baltim). 2018;97(38):e12291.","journal-title":"Med (Baltim)"},{"issue":"1","key":"871_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000018182","volume":"199","author":"JM Mascaro Jr","year":"1999","unstructured":"Mascaro JM Jr, Ferrando J, Sole MT, Alsina M, Nousari HC, Anhalt GJ, Font J, Mascaro JM. Paraneoplastic pemphigus: a case of long-term survival associated with systemic lupus erythematosus and polymyositis. Dermatology. 1999;199(1):63\u20136.","journal-title":"Dermatology"},{"issue":"1","key":"871_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000017964","volume":"197","author":"V Mahler","year":"1998","unstructured":"Mahler V, Antoni C, Anhalt GJ, Koch HJ, Peters KP, Manger B, Kalden JR, Hornstein OP. Graft-versus-host-like mucocutaneous eruptions with serological features of paraneoplastic pemphigus and systemic lupus erythematosus in a patient with non-hodgkin\u2019s lymphoma. Dermatology. 1998;197(1):78\u201383.","journal-title":"Dermatology"},{"issue":"6","key":"871_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.prp.2007.03.002","volume":"203","author":"M Kojima","year":"2007","unstructured":"Kojima M, Motoori T, Asano S, Nakamura S. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract. 2007;203(6):423\u201331.","journal-title":"Pathol Res Pract"},{"key":"871_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1477-7819-5-45","volume":"5","author":"C Menenakos","year":"2007","unstructured":"Menenakos C, Braumann C, Hartmann J, Jacobi CA. Retroperitoneal Castleman\u2019s tumor and paraneoplastic pemphigus: report of a case and review of the literature. World J Surg Oncol. 2007;5:45.","journal-title":"World J Surg Oncol"},{"issue":"10","key":"871_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1001\/archderm.141.10.1285","volume":"141","author":"J Wang","year":"2005","unstructured":"Wang J, Zhu X, Li R, Tu P, Wang R, Zhang L, Li T, Chen X, Wang A, Yang S, et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol. 2005;141(10):1285\u201393.","journal-title":"Arch Dermatol"},{"issue":"2","key":"871_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1182\/bloodadvances.2021004441","volume":"6","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee S, Martin R, Sande B, Paige JS, Fajgenbaum DC. Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6-directed therapy. Blood Adv. 2022;6(2):359\u201367.","journal-title":"Blood Adv"},{"issue":"23","key":"871_CR27","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","volume":"4","author":"F van Rhee","year":"2020","unstructured":"van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020;4(23):6039\u201350.","journal-title":"Blood Adv"},{"issue":"3","key":"871_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/ajcp\/aqaa053","volume":"154","author":"L Wang","year":"2020","unstructured":"Wang L, Nong L, Li F, Wang X, Wang R, Chen X, Tu P, Dong Y, Li T, Zhu X, et al. Predominant stroma-rich feature in Hyaline Vascular variant of Castleman Disease is Associated with Paraneoplastic Pemphigus. Am J Clin Pathol. 2020;154(3):403\u201313.","journal-title":"Am J Clin Pathol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00871-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00871-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00871-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:43:20Z","timestamp":1700239400000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00871-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00871-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2912254\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The First Affiliated Hospital, Henan University of Science and Technology (Approval number: 2021-03-B052).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Verbal informed consent was obtained prior to the interview.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"126"}}